16-JUN-2024 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 283 10 522 55 670 99 603
ERLYTX 41 1 52 3 37 6 37
GI 209 3 157 21 256 45 274
GU 531 14 730 45 548 95 578
LEUK 49 0 0 2 24 8 49
LUNG 804 14 730 57 694 127 773
LYMPH 177 4 209 20 244 46 280
MELAN 458 7 365 54 657 93 566
MMYEL 178 7 365 32 390 70 426
MULT 16 2 104 4 49 9 55
OTHER 55 1 52 9 110 15 91
PREV 6 0 0 1 12 2 12
SXQOL 6 0 0 1 12 2 12
Total 2813 63 3286 304 3703 617 3756

16-JUN-2024 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 2 104 2 24 2 12
BREAST 1 0 0 0 0 1 6
CCD 904 11 574 54 657 135 822
ERLYTX 9 1 52 1 12 1 6
GU 6 1 52 3 37 4 24
LUNG 344 5 261 24 292 47 286
OTHER 7 0 0 1 12 1 6
PREV 571 6 313 34 414 82 499
SURV 22 0 0 3 37 5 30
SXQOL 1449 12 626 52 633 169 1029
Total 3315 38 1982 174 2118 447 2720

16-JUN-2024 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 2 104 2 24 2 12
BREAST 284 10 522 55 670 100 609
CCD 904 11 574 54 657 135 822
ERLYTX 50 2 104 4 49 7 43
GI 209 3 157 21 256 45 274
GU 537 15 783 48 584 99 603
LEUK 49 0 0 2 24 8 49
LUNG 1148 19 991 81 986 174 1059
LYMPH 177 4 209 20 244 46 280
MELAN 458 7 365 54 657 93 566
MMYEL 178 7 365 32 390 70 426
MULT 16 2 104 4 49 9 55
OTHER 62 1 52 10 122 16 97
PREV 577 6 313 35 426 84 511
SURV 22 0 0 3 37 5 30
SXQOL 1455 12 626 53 645 171 1041
Total 6128 101 5269 478 5820 1064 6477

16-JUN-2024 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 172 4 209 30 365 56 341
ERLYTX 34 0 0 2 24 5 30
GI 177 3 157 19 231 41 250
GU 433 10 522 38 463 82 499
LEUK 32 0 0 1 12 5 30
LUNG 543 8 417 34 414 80 487
LYMPH 148 1 52 15 183 37 225
MELAN 275 2 104 30 365 49 298
MMYEL 121 5 261 19 231 43 262
MULT 6 0 0 2 24 4 24
OTHER 55 1 52 9 110 15 91
PREV 6 0 0 1 12 2 12
SXQOL 6 0 0 1 12 2 12
Total 2008 34 1774 201 2446 421 2561

16-JUN-2024 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 2 104 2 24 2 12
BREAST 1 0 0 0 0 1 6
CCD 801 9 470 50 609 120 731
ERLYTX 8 0 0 0 0 0 0
GU 5 0 0 2 24 3 18
LUNG 202 5 261 17 207 28 170
OTHER 7 0 0 1 12 1 6
PREV 389 5 261 31 377 58 353
SURV 16 0 0 3 37 5 30
SXQOL 944 9 470 31 377 111 676
Total 2375 30 1566 137 1667 329 2002

16-JUN-2024 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 2 104 2 24 2 12
BREAST 217 6 313 39 475 75 457
CCD 819 11 574 51 621 123 749
ERLYTX 42 0 0 2 24 5 30
GI 181 3 157 17 207 39 237
GU 452 12 626 38 463 89 542
LEUK 32 0 0 1 12 5 30
LUNG 745 13 678 51 621 108 657
LYMPH 148 1 52 15 183 37 225
MELAN 275 2 104 30 365 49 298
MMYEL 118 4 209 20 244 44 268
MULT 11 0 0 4 49 6 37
OTHER 77 1 52 11 134 22 134
PREV 395 5 261 32 390 60 365
SURV 16 0 0 3 37 5 30
SXQOL 950 9 470 32 390 113 688
Total 4480 69 3600 348 4239 782 4759

16-JUN-2024 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 231 9 470 51 621 91 554
ERLYTX 35 1 52 3 37 6 37
GI 88 2 104 7 85 21 128
GU 266 7 365 17 207 41 250
LEUK 35 0 0 1 12 7 43
LUNG 740 13 678 55 670 123 749
LYMPH 119 4 209 15 183 30 183
MELAN 9 0 0 4 49 5 30
MMYEL 154 7 365 29 353 64 390
MULT 16 2 104 4 49 9 55
Total 1693 45 2347 186 2266 397 2419

16-JUN-2024 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1908 28 1461 175 2131 373 2271
AFFIL 225 5 261 24 292 49 298
CCOP/NCORP 2250 31 1618 139 1692 328 1997
Non-SWOG 1741 33 1722 136 1656 310 1887
Total 6124 97 5062 474 5771 1060 6453

16-JUN-2024 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK MM1YA-S01 AML, High Risk, Age <60, 7+3 vs experimental 1 Y 16-MAY-24
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 Y 16-MAY-24
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 2 Y 16-MAY-24
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 3 Y 16-MAY-24
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 4 Y 16-MAY-24

16-JUN-2024 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
PREV S1823 GCT, Obs. Cohort, miRNA371 1 N 20-MAY-24
PREV S1904 Breast, Decision making for chemoprevention 1 N 14-JUN-24
OTHER N0577 BRN, Glio,Tem vs Tem+RT vsRT+PVC 0 E 10-JUN-24
OTHER N0577 BRN, Glio,Tem vs Tem+RT vsRT+PVC 1 E 10-JUN-24
SXQOL A221805 Colorectal, Duloxetine for Oxaliplatin CIPN 1 E 07-JUN-24
SXQOL A221805 Colorectal, Duloxetine for Oxaliplatin CIPN 2 E 07-JUN-24

16-JUN-2024 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
LUNG S2302 NSCLC, Stg IV or Recur, Ramu + Pembro vs SoC 1 9
CCD S2108CD Genomic Tumor Board vs Usual Practice 1 8
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 2 6
SXQOL S2010 ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 6
MELAN S2015 MELAN, Stg I-II, 1cm v 2cm excision margins 1 6
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 6
GU EA8212 Blad, NMIBC, BRIDGE 1 5
LUNG LUNGMAP NSCLC, Adv, Master 1 5
GU S1802 Pros, Stg IV, SST +/- Surg/RT to Primary Tum 1 5
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 5
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 1 4
LUNG S1914 NSCLC, High Risk Early Stg, SBRT +/- Atezo 1 4
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 4
LUNG LUNGMAP NSCLC, Adv, Master 2 3
PREV S1904 Breast, Decision making for chemoprevention 1 3
CCD S1912CD CREDIT, Fin Counseling to reduce Fin Hardship 1 3
LYMPH S2114 NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3